Ethotoin: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|Overview of the anticonvulsant drug Ethotoin}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| image = Ethotoin_synthesis.png | |||
| image_size = 250px | |||
| image_alt = Synthesis of Ethotoin | |||
}} | |||
'''Ethotoin''' is an [[anticonvulsant]] medication used primarily in the treatment of [[epilepsy]]. It is a member of the [[hydantoin]] class of drugs, which are known for their ability to stabilize neuronal membranes and reduce seizure activity. | |||
Ethotoin | |||
== | ==Pharmacology== | ||
Ethotoin works by modulating the activity of [[sodium channels]] in the brain, which helps to prevent the excessive electrical activity that leads to seizures. Unlike some other anticonvulsants, Ethotoin is less likely to cause [[gingival hyperplasia]] or [[hirsutism]]. | |||
== | ==Medical uses== | ||
Ethotoin is indicated for the management of [[tonic-clonic seizures]] and [[complex partial seizures]]. It is often used when other anticonvulsants, such as [[phenytoin]], are not well tolerated by the patient. | |||
== | ==Side effects== | ||
Ethotoin | Common side effects of Ethotoin include [[drowsiness]], [[dizziness]], and [[ataxia]]. In some cases, patients may experience [[nausea]], [[vomiting]], or [[skin rash]]. Long-term use can lead to [[osteoporosis]] and [[folate deficiency]]. | ||
== | ==Synthesis== | ||
Ethotoin | [[File:Ethotoin_synthesis.png|thumb|right|250px|Synthesis of Ethotoin]] | ||
The synthesis of Ethotoin involves the reaction of [[ethyl acetoacetate]] with [[urea]] in the presence of a base to form the hydantoin ring. This process is a classic example of the [[Bucherer–Bergs reaction]], which is commonly used in the synthesis of hydantoin derivatives. | |||
== | ==History== | ||
Ethotoin | Ethotoin was first introduced in the 1950s as an alternative to other anticonvulsants. It was developed to provide a treatment option with fewer side effects compared to [[phenobarbital]] and [[phenytoin]]. | ||
==Related pages== | |||
* [[Epilepsy]] | |||
* [[Anticonvulsant]] | |||
* [[Hydantoin]] | |||
* [[Phenytoin]] | |||
[[Category:Anticonvulsants]] | [[Category:Anticonvulsants]] | ||
[[Category: | [[Category:Hydantoins]] | ||
Latest revision as of 10:56, 15 February 2025
Overview of the anticonvulsant drug Ethotoin
Ethotoin is an anticonvulsant medication used primarily in the treatment of epilepsy. It is a member of the hydantoin class of drugs, which are known for their ability to stabilize neuronal membranes and reduce seizure activity.
Pharmacology[edit]
Ethotoin works by modulating the activity of sodium channels in the brain, which helps to prevent the excessive electrical activity that leads to seizures. Unlike some other anticonvulsants, Ethotoin is less likely to cause gingival hyperplasia or hirsutism.
Medical uses[edit]
Ethotoin is indicated for the management of tonic-clonic seizures and complex partial seizures. It is often used when other anticonvulsants, such as phenytoin, are not well tolerated by the patient.
Side effects[edit]
Common side effects of Ethotoin include drowsiness, dizziness, and ataxia. In some cases, patients may experience nausea, vomiting, or skin rash. Long-term use can lead to osteoporosis and folate deficiency.
Synthesis[edit]
The synthesis of Ethotoin involves the reaction of ethyl acetoacetate with urea in the presence of a base to form the hydantoin ring. This process is a classic example of the Bucherer–Bergs reaction, which is commonly used in the synthesis of hydantoin derivatives.
History[edit]
Ethotoin was first introduced in the 1950s as an alternative to other anticonvulsants. It was developed to provide a treatment option with fewer side effects compared to phenobarbital and phenytoin.
